Early research (Phase 1)Study completedNCT03381183
What this trial is testing
IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
Who this might be right for
Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell Carcinoma+5 more
H. Lee Moffitt Cancer Center and Research Institute 19